FCF Industrial Machinery Market Study – 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Industrial Machinery Market Study – 2021”. Based on available data from European industrial machinery producers, the FCF Industrial Machinery Market Study is a
FCF Life Sciences SPAC Monitor – 05/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences SPAC Monitor – 05/2021”. The Monitor is a quarterly published overview focusing on the performance of life sciences companies after the
FCF Life Sciences: Cool off for SPAC-Boom
Number of SPAC IPOs has stagnated since April Potential reason could be a Statement from U.S. Securities and Exchange Commission (SEC) 611 SPAC IPOs since May 2020 Munich, May 18, 2021 – The boom around
FCF Valuation Monitor – Q1 2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q1 2021”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment and
Boom in biotech venture capital financing
Financing volume in the USA doubled in the first quarter of 2021 High growth also in Europe Munich, May 05, 2021 – The boom in biotech venture capital financing continues: In the US, the venture
FCF Biotech Venture Capital Monitor – USA 04/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 04/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Life Sciences in the Börse Online magazine | 19. April 2021
FCF Life Sciences in the Börse Online magazine | 19. April 2021 The Life Sciences team at FCF Fox Corporate Finance has recently published an analysis on Special Purpose Acquisition Companies (SPACs) with a focus
FCF Biotech Venture Capital Monitor – USA 03/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 03/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Life Sciences: Boom Bei Healthcare-SPACS Ungebrochen | GoingPublic 13.04.2021
Der Boom um Special Purpose Acquisition Companies, auch SPACs genannt, setzt sich 2021 ungebremst fort. Lag die Zahl der SPAC-Börsengänge im gesamten Jahr 2020 noch bei 306 SPAC-IPOs, liegt sie in den ersten drei Monaten
FCF Life Sciences Venture Capital Monitor – Europe 02/2021 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 02/2021”. The Monitor is a monthly published overview of venture capital trends in the European Life